OraSure (OSUR) launched its HEMAcollect PROTEIN product to meet the evolving needs of proteomic researchers. The product, developed by OTI subsidiary DNA Genotek, is an evacuated blood collection tube designed to preserve and stabilize plasma proteins in whole blood for up to seven days. Currently available for research use only, the collection tube with its proprietary stabilizing liquid preserves plasma proteins, facilitating storage and transport of blood samples at ambient temperature, which are limitations of general blood collection tubes.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSUR:
- OraSure files $300M mixed securities shelf
- Hold Rating on Orasure Technologies Amid 23andMe Acquisition and Revenue Uncertainties
- Evercore says 23andMe buyout removes downside case for OraSure
- OraSure up 5% to $2.55 after Evercore sees downside case removed
- OraSure Technologies Approves Stock Plan Amendment at Annual Meeting